<VariationArchive VariationID="2761937" VariationName="NM_020964.3(EPG5):c.102del (p.Ser35fs)" VariationType="Deletion" Accession="VCV002761937" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-07-23" DateCreated="2024-02-14" MostRecentSubmission="2024-07-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2911466" VariationID="2761937">
      <GeneList>
        <Gene Symbol="EPG5" FullName="ectopic P-granules 5 autophagy tethering factor" GeneID="57724" HGNC_ID="HGNC:29331" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>18q12.3-21.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="18" Accession="NC_000018.10" start="45800581" stop="45967329" display_start="45800581" display_stop="45967329" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="18" Accession="NC_000018.9" start="43427573" stop="43547304" display_start="43427573" display_stop="43547304" Strand="-" />
          </Location>
          <OMIM>615068</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_020964.3(EPG5):c.102del (p.Ser35fs)</Name>
      <CanonicalSPDI>NC_000018.10:45955299:GG:G</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>18q21.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="18" Accession="NC_000018.10" start="45955300" stop="45955300" display_start="45955300" display_stop="45955300" variantLength="1" positionVCF="45955299" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="18" Accession="NC_000018.9" start="43535266" stop="43535266" display_start="43535266" display_stop="43535266" variantLength="1" positionVCF="43535265" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>S35fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000018.10" sequenceAccession="NC_000018" sequenceVersion="10" change="g.45955301del" Assembly="GRCh38">
            <Expression>NC_000018.10:g.45955301del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000018.9" sequenceAccession="NC_000018" sequenceVersion="9" change="g.43535267del" Assembly="GRCh37">
            <Expression>NC_000018.9:g.43535267del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_042838.1" sequenceAccession="NG_042838" sequenceVersion="1" change="g.17040del">
            <Expression>NG_042838.1:g.17040del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001410858.1" sequenceAccession="NM_001410858" sequenceVersion="1" change="c.102del">
            <Expression>NM_001410858.1:c.102del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001397787.1" sequenceAccession="NP_001397787" sequenceVersion="1" change="p.Ser35fs">
            <Expression>NP_001397787.1:p.Ser35fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001410859.1" sequenceAccession="NM_001410859" sequenceVersion="1" change="c.102del">
            <Expression>NM_001410859.1:c.102del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001397788.1" sequenceAccession="NP_001397788" sequenceVersion="1" change="p.Ser35fs">
            <Expression>NP_001397788.1:p.Ser35fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_020964.3" sequenceAccession="NM_020964" sequenceVersion="3" change="c.102del" MANESelect="true">
            <Expression>NM_020964.3:c.102del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_066015.2" sequenceAccession="NP_066015" sequenceVersion="2" change="p.Ser35fs">
            <Expression>NP_066015.2:p.Ser35fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1234" sequenceAccession="LRG_1234">
            <Expression>LRG_1234:g.17040del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1234t1" sequenceAccession="LRG_1234t1">
            <Expression>LRG_1234t1:c.102del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1234p1" sequenceAccession="LRG_1234p1" change="p.Ser35fs">
            <Expression>LRG_1234p1:p.Ser35fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_020964.2" sequenceAccession="NM_020964" sequenceVersion="2" change="c.102del">
            <Expression>NM_020964.2:c.102del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_020964.3(EPG5):c.102del (p.Ser35fs) AND Vici syndrome" Accession="RCV003540371" Version="1">
        <ClassifiedConditionList TraitSetID="9271">
          <ClassifiedCondition DB="MedGen" ID="C1855772">Vici syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-09-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_020964.3(EPG5):c.102del (p.Ser35fs) AND not provided" Accession="RCV004593362" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-05-20" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-05-20" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2024-02-14" MostRecentSubmission="2024-07-23">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">23222957</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23674064</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="9271" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2298" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Absent corpus callosum cataract immunodeficiency</ElementValue>
                <XRef ID="Absent+Corpus+Callosum+Cataract+Immunodeficiency/81" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Immunodeficiency with cleft lip/palate, cataract, hypopigmentation and absent corpus callosum</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Vici syndrome</ElementValue>
                <XRef ID="MONDO:0009452" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">VICIS</ElementValue>
                <XRef Type="MIM" ID="242840" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="448" />
                <XRef ID="448" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">EPG5-Related Vici Syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">EPG5 Deficiency</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">EPG5-Related Disorder</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">With the current widespread use of multigene panels and comprehensive genomic testing, it has become apparent that the phenotypic spectrum of EPG5-related disorder represents a continuum. At the most severe end of the spectrum is classic Vici syndrome (defined as a neurodevelopmental disorder with multisystem involvement characterized by the combination of agenesis of the corpus callosum, cataracts, hypopigmentation, cardiomyopathy, combined immunodeficiency, microcephaly, and failure to thrive); at the milder end of the spectrum are attenuated neurodevelopmental phenotypes with variable multisystem involvement. Median survival in classic Vici syndrome appears to be 24 months, with only 10% of children surviving longer than age five years; the most common causes of death are respiratory infections as a result of primary immunodeficiency and/or cardiac insufficiency resulting from progressive cardiac failure. No data are available on life span in individuals at the milder end of the spectrum.</Attribute>
                <XRef ID="NBK584989" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">36228046</ID>
                <ID Source="BookShelf">NBK584989</ID>
              </Citation>
              <XRef ID="1493" DB="Orphanet" />
              <XRef ID="C1855772" DB="MedGen" />
              <XRef ID="MONDO:0009452" DB="MONDO" />
              <XRef Type="MIM" ID="242840" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8011658" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="27800013|MedGen:C1855772" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004324361" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23222957</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23674064</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Ser35Valfs*17) in the EPG5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EPG5 are known to be pathogenic (PMID: 23222957, 23674064). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with EPG5-related conditions. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EPG5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000018.9:g.43535266del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1855772" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9863125" SubmissionDate="2024-07-17" DateLastUpdated="2024-07-23" DateCreated="2024-07-23">
        <ClinVarSubmissionID localKey="GDXSV:479976" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV005079814" DateUpdated="2024-07-23" DateCreated="2024-07-23" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-05-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="EPG5" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:7201788</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_020964.2:c.102del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_313_20240717054204</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9863125" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8011658" TraitType="Disease" MappingType="XRef" MappingValue="C1855772" MappingRef="MedGen">
        <MedGen CUI="C1855772" Name="Vici syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

